Eckert & Ziegler SEMIL:1EUZ 80 PB Ratio is 3.55 as of Jul. 07, 2026, which is 5% below its 10-year median of 3.72. GuruFocus rates MIL:1EUZ with a GF Score™ of 80/100 and a GF Value™ of €16.66 (Fairly Valued). Among 788 Medical Devices & Instruments companies, Eckert & Ziegler SE ranks worse than 70.81% on this metric.
Eckert & Ziegler SE stock PB Ratio (=3.71) is close to 1-year low of 3.36.
The historical rank and industry rank for Eckert & Ziegler SE's PB Ratio or its related term are showing as below:
MIL:1EUZ'
s PB Ratio Range Over the Past 10 Years
Min: 0.93 Med: 3.72 Max: 14.91
Current: 3.71
During the past 13 years, Eckert & Ziegler SE's highest PB Ratio was 14.91. The lowest was 0.93. And the median was 3.72.
MIL:1EUZ's PB Ratio is ranked worse than 70.81% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs MIL:1EUZ: 3.71
During the past 12 months, Eckert & Ziegler SE's average Book Value Per Share Growth Rate was 16.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 9.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 10.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Eckert & Ziegler SE was 15.30% per year. The lowest was 1.10% per year. And the median was 7.30% per year.
Back to Basics: PB Ratio
Eckert & Ziegler SE (MIL:1EUZ) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Eckert & Ziegler SE PB Ratio Related Terms
Eckert & Ziegler SE PB Ratio Historical Data
* Premium members only.
The historical data trend for Eckert & Ziegler SE's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Eckert & Ziegler SE's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's PB Ratio distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Eckert & Ziegler SE (MIL:1EUZ) has a PB Ratio of 3.55 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Eckert & Ziegler SE and its competitors. This is near median its historical median of 3.72. Over the past decade, Eckert & Ziegler SE's PB Ratio has ranged from 0.93 to 14.91. According to the industry distribution chart, Eckert & Ziegler SE ranks #558 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 70.8%.
Is Eckert & Ziegler SE's PB Ratio too high?
Eckert & Ziegler SE's current PB Ratio of 3.55 is near median its 10-year median of 3.72. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 14.91. The Medical Devices & Instruments industry median PB Ratio is 2.05. Eckert & Ziegler SE's value of 3.55 is 73.2% above this industry median. Based on the distribution chart, Eckert & Ziegler SE ranks #558 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eckert & Ziegler SE has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eckert & Ziegler SE ranks #558 out of 788 companies for PB Ratio. This places Eckert & Ziegler SE in the lower half of its industry. The industry median PB Ratio is 2.05. Eckert & Ziegler SE's value of 3.55 is 73.2% above this benchmark. Historically, Eckert & Ziegler SE's own PB Ratio has ranged from 0.93 to 14.91 over the past decade. While the company's 10-year median is 3.72 vs. the industry median of 2.05, Eckert & Ziegler SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eckert & Ziegler SE's current PB Ratio of 3.55 is 73.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Eckert & Ziegler SE and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eckert & Ziegler SE's current PB Ratio is 3.55, which is near median its own 10-year median of 3.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (MIL:1EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.66, compared to a current price of €15.24 — trading 8.5% below its estimated fair value. The current PB Ratio is 3.55, which is near median its 10-year median of 3.72 and 73.2% above the Medical Devices & Instruments industry median of 2.05. Eckert & Ziegler SE's overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Eckert & Ziegler SE (MIL:1EUZ), the current PB Ratio is 3.55 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eckert & Ziegler SE (MIL:1EUZ) Overvalued in 2026?
Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued.
The current stock price of €15.24 is trading 8.5% below its estimated GF Value™ of €16.66.
GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.
Key valuation signals for MIL:1EUZ:
PB Ratio: 3.55 (near median its 10-year median of 3.72)
GF Value™: €16.66 vs. price of €15.24 (8.5% below fair value)
Industry Position: 73.2% above the Medical Devices & Instruments median (#558 of 788)
No single metric tells the full story. See the MIL:1EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
80GF Score
Get the complete analysis for MIL:1EUZ
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1EUZ has been successfully added to your 
